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Abstract
The pulmonary route represents one of the most important portals of entry for nanoparticles into
the body. However, the in vivo interactions of nanoparticles with biomolecules of the lung have
not been sufficiently studied. Here, using an established mouse model of pharyngeal aspiration of
single-walled carbon nanotubes (SWCNTs), we recovered SWCNTs from the bronchoalveolar
lavage fluid (BALf), purified them from possible contamination with lung cells and examined the
composition of phospholipids adsorbed on SWCNTs by liquid chromatography mass spectrometry
(LC-MS) analysis. We found that SWCNTs selectively adsorbed two types of the most abundant
surfactant phospholipids – phosphatidylcholines (PC) and phosphatidylglycerols (PG). Molecular
speciation of these phospholipids was also consistent with pulmonary surfactant. Quantitation of
adsorbed lipids by LC-MS along with the structural assessments of phospholipid binding by
atomic force microscopy and molecular modeling indicated that the phospholipids (~108
molecules per SWCNT) formed an uninterrupted “coating” whereby the hydrophobic alkyl chains
of the phospholipids were adsorbed onto the SWCNT with the polar head groups pointed away
from the SWCNT into the aqueous phase. In addition, the presence of surfactant proteins A, B and
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D on SWCNTs was determined by LC-MS. Finally, we demonstrated that the presence of this
surfactant coating markedly enhanced the in vitro uptake of SWCNTs by macrophages. Taken
together, this is the first demonstration of the in vivo adsorption of the surfactant lipids and
proteins on SWCNTs in a physiologically relevant animal model.
Keywords
carbon nanotubes; surfactant; macrophages; mass spectrometric analysis
The numerous emerging applications of nanotechnologies necessitate a detailed
understanding of the interfaces of nanomaterials with biological systems, including
interactions with components of biofluids, especially at sites of entry of nanomaterials into
the body. The lung is one of the main portals of entry for inhaled nanoparticles where they
can interact with pulmonary biosurfaces i.e. cells and surfactant.1 Subsequently, the inhaled
nanoparticles may translocate from the lung into secondary target organs in a size- and
surface charge-dependent manner.2
Pulmonary surfactant consists of lipids (90%) and proteins (10%) and plays a crucial role in
respiratory functions as a biophysical entity to reduce surface tension at the air-water
interface. It facilitates gas exchange and alveolar stability and acts as an innate component
of the lung's immune system to maintain sterility and balance immune reactions in the distal
airways. Surfactant proteins (SP-A, SP-B, SP-C, and SP-D) and their distinct interactions
with surfactant phospholipids are essential for the ultra-structural organization, stability,
metabolism, and the lowering of surface tension to prevent alveolar collapse. In addition,
SP-A and SP-D bind pathogens, inflict damage to microbial membranes, and regulate
microbial phagocytosis and activate or deactivate inflammatory responses by alveolar
macrophages.3, 4 Previous in vitro studies have demonstrated the adsorption of pulmonary
surfactant phospholipids on nano-sized gold particles and carbon black particles.5
Upon incubation with human plasma, nanoparticles have been shown to acquire a “corona”
of proteins as well as lipids6, 7, 8 that may influence cellular uptake and toxicity of
nanomaterials.9, 10 For instance, Ge et.al11 reported that the binding of human serum
proteins to single-walled carbon nanotubes (SWCNTs) strongly reduced their toxic
potential. We previously showed that the adsorption of an anionic phospholipid,
phosphatidylserine (PS), onto the surface of SWCNTs promoted their uptake by murine and
human macrophages and dendritic cells of the immune system.12 However, the in vivo
adsorption of biomolecules on nanomaterials following pulmonary exposure has not been
characterized. The binding of components of pulmonary surfactant with the surface of
nanoparticles may be compared with the opsonization of pathogens, eg. bacteria, viruses or
allergen particles.13 Thus, it is likely that the coating of nanoparticles with proteins and/or
lipids will confer a new biological “identity” defining, to a large extent, their recognition by
cells of the innate immune system which, in turn, may affect their biodistribution.14
In the present study, we determined the interactions of SWCNTs with pulmonary surfactant
components and the consequences of surfactant coating for their phagocytosis by
macrophages. Using an established mouse model of pharyngeal aspiration of SWCNTs, we
recovered SWCNTs with the bronchoalveolar lavage fluid (BALf) after aspiration, purified
them from possible contamination by lung alveolar cells and examined their phospholipid
composition by LC-MS analysis. We found that SWCNTs specifically adsorbed major
surfactant phospholipids along with surfactant proteins A, B and D. This surfactant-like
“aura” of SWCNTs markedly enhanced their recognition and uptake by RAW264.7
macrophages.
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RESULTS AND DISCUSSION
The in vivo coating of SWCNTs by lipid and protein components of surfactant
To characterize the ability of SWCNTs to adsorb pulmonary lipids in vivo, LC-MS analysis
of phospholipids in organic extracts of SWCNTs recovered by sucrose gradient purification
from BALf of mice 2 and 24 h after pharyngeal aspiration of SWCNTs was performed
(Figure 1, A, B, C). The presence of cells in BALf was excluded prior to MS analysis (see
Materials and Methods). The composition of the SWCNT-adsorbed phospholipids was
essentially the same at the 2 and 24 h time points. Although all major classes of
phospholipids were detected, the spectra of nanomaterial-bound lipids reflected lipid profiles
typical of surfactant lipids. Two phospholipids of BALf - PC and PG15, 16, 17, 18 - were the
dominant components in the spectra (Figure 1, A). No phospholipid signals were detected in
the spectra of extracts from control samples obtained from non-exposed animals (Figure 1,
B). Similarly, control extracts of the SWCNT suspensions were devoid of lipid signals
(Figure 1, C). Expectedly, relatively low intensity signals from PC species were observed in
the negative ion mode LC-MS chromatograms (Figure 1, A). MALDI-MS analysis of the
SWCNT lipids in positive ionization mode confirmed the predominance of PC whereby
DPPC (16:0/16:0) represented the dominant PC species (Figure 1, D). LC-MS-analysis
revealed five individual molecular species of PC (m/z 740, 768, 778,792, 808, which run as
Cl adducts) and four species of PG (m/z 721, 747, 769 and 793) (Figure 1, A). Quantitative
analysis performed by LC-MS indicated that PC was accountable for 74% of the total
phospholipids adsorbed on the SWCNT (178.0 pmol/nmol of inorganic lipid phosphorous
(Pi) (Figure 1, E). PG represented 14% of the SWCNT phospholipids (31.3 pmol/nmol of
Pi). The remaining 12% of lipids was distributed fairly equally among PS, PI and PE, (5%,
3% and 3% respectively) with minimal amounts (1%) of sphingomyelin. Specifically, three
species of PE (m/z 722, 746 and 762), two species each for PI (m/z 885 and 857) and PS (m/
z 810 and 834) and only one species of sphingomyelin were detected. Fatty acyl
composition as well as percent abundances corresponding to these species of phospholipids
are given in Table 1. Dipalmitoyl phosphatidylcholine (DPPC, m/z 768, chloride adduct)
dominated (up to 60%) as the major PC species while 16:0/18:1 PG, 16:0/18:2 PG
(combined) and 16:0/16:0 PG represented the major PG species (up to 52 and 26%,
respectively). These assessments are in excellent agreement with the published estimates of
the phospholipid content (~90% of total lipids) in BALf.15, 16, 17, 18 The ranges for major
phospholipid components of the surfactant have been reported as follows: PC, 70–80% (up
to 70% of this can be DPPC); PG, 7–18%; PS, 3–5%; PI, 2–4%; PE, 2–3% and SM, < 2%.
Notably, this surfactant-specific pattern of SWCNT-adsorbed phospholipids and their
individual molecular species is distinctly different from the phospholipid profile of the
mouse lung where PC, PE and PS represent the most abundant species.19 Furthermore, the
molecular speciation of the SWCNT-adsorbed lipids detected here is also markedly different
from lung phospholipids. Indeed, PC (16:1/18:2) and PC (16:0/20:4) are the most abundant
pulmonary species of phospholipids in the lung.19
Given that SWCNTs selectively adsorbed surfactant phospholipids following pharyngeal
aspiration, we further conducted protein analysis to determine the extent to which surfactant
proteins were also bound to SWCNTs. Proteomic analysis of SWCNT-associated proteins
by SDS-PAGE with subsequent MS of in-gel digests revealed several bands represented
mostly by proteins with molecular weights of more than 50 kDa; some of the proteins had
very high-molecular weights and could not penetrate into stacking or running gel (Figure 2).
Similar to the data with phospholipids, the composition of the SWCNT-adsorbed proteins
was essentially the same at the 2 and 24 h time points. MS analysis of SWCNT-bound
proteins was performed to identify the possible presence of surfactant proteins. Four protein
bands were selected based on their intensity by silver staining and their ability to be excised
as a single protein band for analysis. Approximately 80 peaks were detected in the LC-MS
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spectra of the tryptic digests from each gel band. Few, if any, of these were strong enough
for MS/MS identification. This was somewhat expected from the limited amount of proteins
associated with SWCNTs and their recovery from in-gel digestion. Nonetheless, three
mouse lung-related proteins (surfactant associated proteins A, B, and D – Figure 2) were
matched by mass profile fingerprinting. Three to seven mass profile fragments of surfactant
A, B and D proteins in various combinations were detected in the four gel bands. SP-A, SP-
B, and SP-D have all been detected in mouse BALf.20, 21, 22 Since the samples were not
reduced prior to the SDS-PAGE separation, these proteins presumably aggregated and
appeared as oligomers in several of the gel bands (Figure 2). Taken together, our data show
that surfactant lipids and proteins are adsorbed on the SWCNT surface after pharyngeal
aspiration in mice.
Two families of surfactant-associated proteins have been purified from surfactant: the high-
molecular-weight hydrophilic SP-A and SP-D and the low-molecular-weight hydrophobic
SP-B and SP-C.4 We found that SP-A, SP-B and SP-D, but not SP-C were adsorbed on
SWCNT. One of the possible reasons for this is the relatively lower abundance of SP-C.
Indeed, SP-A constitutes approximately 3–4% of the total mass of isolated surfactant and
50% of the total surfactant protein, while SP-B comprises 10% (w/w) of the total surfactant
protein. Surfactant proteins SP- C and SP-D were found in smaller amounts.4 Our previous
work established that SWCNT induce robust inflammation in the lung of mice 23
accompanied by the production and release of a variety of inflammatory mediators,
including TNF-alpha. SP-C expression can be regulated by inflammation (eg, following
bleomycin treatment, hyperoxia or by pathogens), mostly due to the released cytokines,
particularly TNF-alpha, which has been shown to decrease SP-C transcription and protein
expression levels.24, 25 Thus, SP-C levels are expectedly lower in a pro-inflammatory
environment induced by the SWCNT exposure. Another reason of the absence of SP-C in
our gels is its characteristic very small molecular weight (of approximately 3.7 kDa) and
high degree of hydrophobicity. In addition, SP-C is soluble in 80% acetonitrile or
chloroform and palmitoylation of its cysteine residues adds to the hydrophobic character of
this protein.26, 27 Our computer modeling indicated that the fatty acyl chains of
phospholipids preferentially associate with SWCNTs with the polar (hydrophilic) head
groups oriented outward toward the solution. This may diminish the interactions between the
low concentrations of the very hydrophobic SP-C molecules with SWCNT coated with high
amounts of surfactant phospholipids.
We attempted to assess what fraction of lipids and proteins present in surfactant were
adsorbed by SWCNTs. In these evaluations, we kept in mind the likely possibility that
SWCNTs have been taken-up by cells and/or redistributed from the airways to other
compartments of the lung. These SWNTs will not be recovered in BALf, hence their
adsorbed constituents will remain undetected. Our calculation of the total amount of
phospholipids retrieved from extracts of the coated SWCNT was in the range of 20–30 μg
per animal. Assuming that the total amount of phospholipids in the surfactant of rodent
species is approximately 220 μg per animal,28 the phospholipids recovered from the
SWCNT represented approximately 9–14% of the total amount of lipid found in surfactant.
Further, lipids account for more than 80% of whole isolated surfactant by weight, while
proteins make up ~10%. About 50–80% of this amount is plasma proteins and the remainder
is made up of the surfactant-specific proteins.29, 30 Thus the total amount of proteins in the
surfactant can be estimated as approximately 20 μg. The amount of proteins adsorbed on
SWCNTs under our conditions was approximately 10–15 μg/5 animals (2–3 μg/animal).
This leads to ~10–15% of surfactant proteins adsorbed on SWCNTs. This suggests that
lipids and proteins were adsorbed on SWCNTs in approximately the same ratio as that found
in surfactant. Similar conclusions can be made from our results that different species of
lipids adsorbed on SWCNTs a ratio similar to that found in surfactant.
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Structural characterization of interactions of surfactant lipids and proteins with SWCNT
To assess the structural aspects of interactions of surfactant lipids and proteins with
SWCNTs, we employed atomic force microscopy (AFM). This technique was applied on
“naked” SWCNTs, SWCNTs incubated with either phospholipids or surfactant protein D
(SP-D), and SWCNTs incubated with both phospholipids and SP-D. AFM revealed that the
“naked” SWCNT lengths varied from 100 to 400 nm with a mean diameter of 1.7 ± 0.5 nm
(n = 50, Figure 3, A, B). SWCNTs incubated with the surfactant phospholipids appeared to
be homogeneously coated with phospholipids yielding a mean diameter of 4.9 ± 2.3 nm (n =
50, Figure 3, C, D) and a mean lipid layer of 3.2 ± 1.8 nm. SP-D produced a continuous
coating on SWCNTs with an wrapping-like pattern, which bestowed a mean height of 4.6 ±
1.9 nm (n = 50) and mean protein layer of 2.9 ± 1.4 nm onto the SWCNT (Figure 3, E, F).
Finally, SWCNTs incubated with both phospholipids and SP-D exhibited an uninterrupted
coating pattern with an average height profile of 7.9 ± 3.8 nm (n = 50, Figure 3, G, H). As a
result, the mean height of the combined phospholipid and SP-D layer demonstrated a
thickness of 6.2 ± 3.3 nm, which is consistent with the data described above.
Molecular modeling of the surfactant coating
Molecular modeling was used to further refine our understanding of SWCNT interactions
with surfactant phospholipids and proteins. The lipid species of the pulmonary surfactant,
DPPC (16:0/16:0), PG (16:0/18:2), PS (18:0/22:6) and PE (18:0/18:0) were docked to
SWCNTs using Autodock Vina31. The predicted binding mode of DPPC, PG, PS and PE on
SWCNTs is shown in Figure 4. In all cases, the analysis of the binding of the two major
phospholipids species, PG and DPPC, indicated that the hydrophobic alkyl chains of these
phospholipids were adsorbed onto the SWCNT with their polar head groups pointed away
from the SWCNT into the aqueous phase. In particular, a tilt in the orientation of the lipid
hydrophobic chain was observed with respect to the alignment of the lipids on the SWCNT
(Figure 4, A, and C–E). A total of eight conformations out of nine were observed to align in
this way, except for one case where the hydrophobic chain was found to be aligned parallel
to the SWCNT axis (Figure 4, B). The alignment of lipid on the SWCNTs and tilt in its
orientation was attributed to hydrogen bonding between the SWCNT and the hydrophobic
lipid chain.32 Using the lowest energy tilted conformation of PG, we further generated a
model by shifting the predicted conformation along the SWCNT axis to understand the
progressive lipid coating on the SWCNT (Figure 4, F). The model is in full agreement with
the regular pattern of striations observed in the AFM studies (Figure 3) and is similar to the
cylindrical encapsulation model described previously for detergents.33 This type of coating
may lead to complete masking and protection of the hydrophobic surface of the SWCNT
from the aqueous environment. Based on these assessments of phospholipid topography on
SWCNTs, we calculated the number of phospholipid molecules adsorbed on a single
SWCNT. A contact area of ~20 nm per lipid molecule was estimated between the lipid
hydrophobic chain and the SWCNT from the docking studies (Figure 4). Assuming a
SWCNT of length 400 nm with a diameter of 1.7 nm and a total surface area of ~2141.7
nm2 (2πr2 + 2πrh), the total number of phospholipids required to coat the SWCNT would
be ~108/SWCNT. This evaluation is in excellent agreement with independent calculations
based on LC-MS measurements of phospholipids according to which the number of
phospholipid molecules in the coating was 115/SWCNT.
To obtain further insights into details of interactions of surfactant proteins with SWCNTs
and surfactant phospholipids, we docked DPPC and SWCNTs to the available 3D crystal
structure of SP-D (Figure 4 G, H). Both lipids and SWCNTs were found to bind at a similar
binding site involving the trimeric interface of the protein, indicating that SP-D can interact
with both lipids and SWCNTs. The interaction of SP-D with DPPC was stabilized via the
head group and not via the acyl chains. This indicates that SP-D has the potential to interact
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with SWCNTs pre-coated with surfactant phospholipids whereby the head groups are
projected away from the SWCNTs. This is in agreement with our MS data documenting the
presence of SP-D on SWCNTs. Unfortunately, we could not perform computer modeling
assessments of SP-C with SWCNTs because the full-length 3D structure of SP-C is not
available. The two available structures in Protein Data Bank (PDB) for SP-C corresponds to
the NMR derived N-terminal propeptide (1–31) part and X-ray structure of BRICHOS
domain (90–197, with sequence from 150–180 missing) of SP-C and lack the S-
palmitoylation sites (i.e., fatty acid chains), thus making it difficult to model the interaction
of SP-C with SWCNT. It is likely that S-palmitoylation of SP-C via covalent attachment of
fatty acids may lead to significant changes in its interaction with the polar head groups are
projected away from the plane of interaction.
The exposure of the polar head groups and the masking of the hydrophobic regions of the
SWCNT could lead to enhanced recognition of SWCNTs by immune cells expressing
specific receptors for lipid-dependent uptake of particulate matter or cellular debris. Indeed,
the stereo-specific binding of PS or PC exposed on the surface of apoptotic cells results in
internalization of these cells by macrophages.34, 35
Effects of surfactant lipids and SP-D on phagocytosis of SWCNTs by macrophages
To determine whether SWCNTs coated with surfactant phospholipids and/or surfactant
proteins are recognized by macrophages, the internalization of SWCNTs with or without a
surfactant coating was assessed using murine RAW264.7 macrophages as a model of
phagocytic cells. Figure 5 demonstrates that the presence of adsorbed phospholipids
significantly enhanced the uptake of SWCNTs when compared with uncoated SWCNTs. To
determine if phagocytosis was dependent on the presentation of specific phospholipids on
SWCNTs, the above experiments were conducted using SWCNTs coated with combinations
of adsorbed surfactant phospholipids whose composition was deficient for the lipid in
question. As can be seen from Figure 5, the absence of PG, PS and PG+PS reduced the
number of macrophages with internalized targets by 4, 9 and 18%, respectively. To
determine whether surfactant proteins could contribute to engulfment, uncoated-SWCNTs or
surfactant-lipid-SWCNTs were mixed with SP-D (1% w/w lipid) and incubated with
macrophages as described above. Inclusion of SP-D alone increased the uptake of uncoated-
SWCNTs by ~7%, while its addition to SWCNTs with surfactant lipids enhanced the
relative uptake by ~10% (Figure 5). Taken together, these data indicate that the association
of SWCNTs with the lipid and protein components of the surfactant markedly altered the
efficiency of their phagocytosis by macrophages.
These in vitro data suggest that the surfactant coating of SWCNTs may determine the
recognition of these nanomaterials in vivo and therefore may impact the biodistribution and
fate of these nanomaterials including their biodegradation.36, 37 The coating of nanoparticles
has been described as a dynamic process whereby a significant exchange of non-covalently
bound “hard” (long-lived) and “soft” coronas takes place; moreover, the corona is dynamic
and may evolve as a result of the transfer of nanoparticles from one biological fluid (eg.
plasma) into another (eg. cytosolic fluid).38, 39 Notably, a recent report indicates that the
binding efficiency to cell lysate proteins appears to depend on the characteristics of the
nanomaterial surface, whereas the adsorbed plasma proteins were suggested to be involved
in particle phagocytosis and covered the nanomaterial independently of its surface
properties.40, 41, 42 Gasser et.al.5 provided evidence that the binding of plasma proteins to
MWCNTs was altered when MWCNTs were previously coated with Curosurf, a natural
surfactant preparation from pig. However, the present study provides the first evidence of
the selective formation of a surfactant-derived lipid-protein coating on SWCNTs in an
animal model of pulmonary exposure.
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CONCLUSIONS
In summary, this work if the first demonstration of the in vivo adsorption of the surfactant
lipids and proteins on SWCNTs in an animal model. Using LC-MS analysis we found that
SWCNT recovered from the bronchoalveolar lavage fluid selectively adsorbed typical
surfactant phospholipids – phosphatidylcholine (PC) and phosphatidylglycerol (PG) and
surfactant proteins A, B and D. Molecular modeling indicates that the adsorbed
phospholipids formed an uninterrupted “coating” whereby the hydrophobic alkyl chains of
the phospholipids were adsorbed onto the SWCNT with the polar head groups pointed away
from the SWCNT into the aqueous phase. The presence of the surfactant coating markedly
enhanced the in vitro uptake of SWCNT by macrophages. The present findings are essential
for our understanding of the toxicological behavior of these nanomaterials but may also have
important implications for nanomedicine and pulmonary delivery of drug-loaded nano-scale
carriers.
METHODS
Reagents
DMEM cell culture medium, fetal bovine serum (FBS), and antibiotics were purchased from
Invitrogen (Carlsbad, CA). 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-
dioleoyl-sn-glycero-3-phospho-L-serine (DOPS), 1,2-dioleoyl-sn-glycero-3-phospho-
glycerol (DOPG), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), L-α-
phosphatidylinositol (Liver, Bovine), sphingomyelin (SM) (Brain, Porcine) were purchased
from Avanti Polar Lipids (Alabaster, AL).
Preparation and characterization of SWCNTs
SWCNTs (CNI Inc., Houston, TX) produced by the high pressure CO disproportionation
process (HiPco) technique43 employing CO in a continuous-flow gas phase as the carbon
feedstock and Fe(CO)5 as the iron-containing catalyst precursor, and purified by acid
treatment to remove metal contaminates44 were used in the study. Chemical analysis of trace
metal (iron) in SWCNTs was performed at the Chemical Exposure and Monitoring Branch
(DART/NIOSH, Cincinnati, OH) using nitric acid dissolution and inductively coupled
plasma-atomic emission spectrometry (ICP-AES). Analysis revealed that SWCNTs were
comprised of 0.23 weight % iron. SWCNTs were routinely tested for bacterial endotoxin
(LPS) contamination using the endpoint chromogenic LAL method, as previously
described.45 The mean diameter and surface area of SWCNTs was 1–4 nm and 1040 m2/g,
respectively. Surface area was determined by Brunauer, Emmett, and Teller (BET) analysis,
and diameter and length was measured by TEM. The chemical cutting of SWCNTs was
performed as reported previously.46 Obtained short SWCNTs were dispersed in 25 mM
HEPES buffer (pH 7.4; containing 150 mM NaCl) by sonication. For purity assessment and
characterization of SWCNTs we used several standard analytical techniques. TEM was
employed to determine the length distribution (Supplementary Figure S2, A). Raman
spectroscopy was implemented to visualize the D and G bands (Supplementary Figure S2,
B). Diffuse reflectance infrared Fourier Transform spectroscopy (DRIFTS) was also
performed (Supplementary Figure S2, C). Preparation of FITC-SWCNTs was performed as
described in the supporting information.
Cells
RAW264.7 mouse macrophage cells obtained from American Tissue Culture Collections
(ATCC) were maintained in DMEM culture medium supplemented with 10% heat-
inactivated fetal bovine serum (FBS), 100 units/ml penicillin and 100 μg/ml streptomycin.
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Animals
Specific pathogen-free adult female C57BL/6 mice were supplied by Jackson Lab (Bar
Harbor, ME) and weighed 20.0 ± 1.9 g at the time of experiment. Animals were housed one
mouse per cage receiving HEPA filtered air National Institute for Occupational Safety and
Health (NIOSH) animal facilities accredited by Association for Assessment and
Accreditation of Laboratory Animal Care. Animals were supplied with water and certified
chow 5020 (Purina Mills, Richmond, IN) ad libitum, and were acclimated in the animal
facility under controlled temperature and humidity for one week prior to use. All
experimental procedures were conducted in accordance with the guidelines of the Institute
of Laboratory Animal Resources (National Research Council) and the experimental protocol
(#07-AS-M-010), approved by the National Institute for Occupational Safety and Health
(NIOSH) Institutional Animal Care and Use Committee.
Pharyngeal aspiration of SWCNTs
Mouse pharyngeal aspiration was used for particulate administration.47 Briefly, after
anesthetization with a mixture of ketamine and xylazine (62.5 and 2.5 mg/kg given
subcutaneously in the abdominal area), the mouse was placed on a board in a near-vertical
position. The animal's tongue was extended with lined forceps and a suspension (~50 μl, 80
μg/mouse) of SWCNT prepared in Ca+2 - Mg+2-free PBS (PBS) was placed posterior of the
pharynx and the tongue which was held until the suspension was aspirated into the lungs.
Control mice were administered sterile Ca2+ + Mg2+-free PBS as a vehicle. The mice were
allowed to revive unassisted after approximately 30–40 min. All mice in SWCNT and PBS
groups survived this exposure procedure.
Obtaining BALf from mice
BALf samples were obtained from mice 2 or 24 h post-pharyngeal aspiration. Mice were
sacrificed with an intra-peritoneal injection of sodium pentobarbital (>100 mg/kg) and
exsanguinated. The trachea was cannulated with a blunted 22 gauge needle, and BAL was
performed using cold sterile PBS at a volume of 0.9 ml for first lavage (kept separate) and
1.0 ml for subsequent lavages. Approximately 5 ml of BALf per mouse was collected in
sterile centrifuge tubes.
SWCNT isolation and purification from BALf
Purified samples of SWCNT were obtained by centrifugation of BALf through 50% sucrose.
The schema used to isolate SWCNT from BALf is presented in Supplementary Figure S4. In
brief, freshly pooled BALf samples (5 mice per group) were centrifuged at 700 × g for 10
min to pellet cells together with SWCNT. Pellets were resuspended in 1 ml PBS, loaded on
top of 3 ml of 50% sucrose and centrifuged at 700 × g for 12 min. Light microscopy
demonstrated that after this procedure practically, all cells were located at the interface of
PBS-sucrose, while the pellet contained only SWCNTs. The pelleted SWCNTs were further
resuspended in PBS and washed 4 times (60,000 × g, 1 h) with the same buffer. No typical
lipid mass ions were found during MS-analysis of the material extracted from pellets
obtained after the centrifugation of BALf from control mice (no SWCNTs) through the 50%
sucrose, confirming the complete removal of cells using this procedure.
MS analysis of lipids adsorbed on SWCNT
Lipids were extracted using the Folch procedure as described previously48 and analyzed by
normal phase chromatography using a Luna normal phase silica column (3 μm particle size
(100 A), 150 × 2 mm, Phenomenex, Torrance, CA) with a flow rate of 0.2 mL/min. Lipids
were eluted using a linear gradient using solvents consisting of chloroform: methanol: 30%
ammonium hydroxide (80:19.5:0.5, v/v/v, solvent A) and chloroform: methanol: water: 30%
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ammonium hydroxide (60:34:5.5:0.5, v/v/v/v, solvent B) over 30 min. Lipids were detected
and analyzed by mass spectrometry on a TSQ 7000 triple quadrupole mass spectrometer.
Mass spectrometer conditions were as follows: spray voltage, 5.0 kV; capillary, 250° C;
sheath gas: 20 psi. Tuning was optimized for all classes of phospholipids across the scan
range. PG (m/z 609) and PC (m/z 628) were utilized as internal standards (IS) in samples for
quantitation. All LC-MS samples were run in the negative ion mode in duplicate which
allowed for the remaining sample to be utilized for inorganic phosphorous analysis. Matrix-
Assisted Laser Desorption Ionization Mass Spectrometry (MALDI-MS) and -MS/MS was
performed with a Bruker Ultraflex II TOF/TOF mass spectrometer (Bruker Daltonics,
Billerica, MA, USA). The matrix compound utilized was 2,5-dihydroxybenzoic acid (DHB)
as 98+% grade from Sigma-Aldrich (St. Louis, MO, USA). Reflector-positive or reflector-
negative modes were used for MALDI-MS as appropriate, and MALDI-MS/MS was
performed using positive mode with a 2 Da mass isolation window.
Analysis of surfactant proteins adsorbed on SWCNT
For analysis of proteins associated with SWCNTs, water- and intermediate phases formed
during lipid extraction were combined and proteins were precipitated by addition of 3
volumes of acetone over night. Proteins were pelleted by centrifugation at 10,000 × g for 30
min, dissolved in 2% SDS and separated by 10% SDS-PAGE in Tris-glycine buffer. The
gels were stained using a SilverSNAP stain kit (Thermo Fisher Scientific, Rockford, IL). For
mass analysis, gel destaining was achieved by a 10 min incubation in a solution containing
15 mM K3Fe(CN)6, 50 mM Na2S2O3 followed by several water washes. Gel pieces were
reduced in the presence of dithiothreitol (DTT) followed by alkylation with iodoacetamide.
Gel pieces were then washed, dehydrated, and dried. The proteins were subjected to
overnight in-gel digestion with trypsin (Promega Gold brand, 25 ng/uL in 25 mM
ammonium bicarbonate buffer, (pH 7.8)). Peptides were extracted with 5% formic acid, 50%
acetonitrile and evaporated to near dryness. Tryptic peptides were analyzed by LC-MS on an
Agilent Eclipse XDB-C18 2.1 mm × 100 mm reverse phase column (0.2 mL/min flow rate;
Solvent A: Water / 0.1% Formic Acid; B: Acetonitrile / 0.1% Formic Acid; Gradient of 2%
to 20% B in 10 minutes, 20% to 40% B in 40 minutes, 40% to 70% B in 15 minutes, 70% to
100% B in 15 minutes, hold at 100% B for 10 minutes, return to 2% B in 20 minutes). Mass
Spectrometry analysis was performed in-line with the LC using a Micromass Premier Q-
TOF (Waters, Milford, MA) equipped with an ESI source and running in V-positive mode.
Mass profile fingerprinting was performed using the Protein Prospector software developed
at the University of California, San Francisco (see P.R. Baker and K.R.. Clauser,
http://prospector.ucsf.edu).
Computer modeling of interactions of SWCNT with surfactant lipids
The lipid species of the pulmonary surfactant, DPPC (16:0/16:0), PG (16:0/18:2), PS
(18:0/22:6) and PE (18:0/18:0) were docked to SWCNT using Autodock Vina.31 The
structures of the phospholipids were extracted from the Lipid Maps and a SWCNT of
diameter 1.3 nm was generated using the Nanotube Modeller Software
(http://www.jcrystal.com/products/wincnt/index.htm). AutoDockTools (ATD) package
(http://autodock.scripps.edu/resources/adt) was further used for formatting and converting
the pdb files to pdbqt format. The docking was performed using the center of the SWCNT as
the grid center and a grid box of size 75Å × 75Å × 75Å. The resulting binding poses were
clustered together and the conformation with the lowest predicted binding energy was
considered for further analysis in each case.
Atomic force microscopy (AFM) of SWCNT with adsorbed lipids and SP-D
As a consequence of the equilibrium established between the CNTs and components of the
dispersion (i.e. lipids), the effect of the “state of dispersion” is critical to the overall
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nanoparticle presentation. Current SWCNT characterization methods have certain
limitations. Indeed, the dry (i.e. AFM) or vacuum (i.e. TEM) characterization methods
inadequately provide insight into the dynamic nature of a nanoparticle in the dispersion.
Moreover, while dynamic light scattering (DLS) (DLS) is a suitable technique for
ascertaining the diameter of particles with spherical shapes in dispersions, only
hydrodynamic diameters can be obtained for SWCNTs utilizing this technique. We selected
AFM in tapping mode to characterize the surfaces of both “naked” and coated CNTs to
obtain a snapshot of the dynamic system at a given point in time. Sample preparation was
made by spin-coating 10 μL of sample at 1,400 revolutions per minute (r. p. m.) on a freshly
cleaved mica substrate that was pretreated with approximately 20 μL of 0.1% (w/w) poly–
L–Lysine (aq) through spin-coating, and the sample was permitted to dry at ambient
temperature for 60 minutes prior to imaging. For imaging, “supersharp” Si probes (tip radius
<5 nm, uncoated, App Nano (Santa Clara, CA)) and a multimode scanning probe
microscope Veeco (Plainview, NY) were utilized in tapping mode to obtain height, phase,
and sectional analysis data.
Coating of SWCNTs with surfactant lipids and SP-D
Small unilamellar vesicles (SUV) composed of the same proportion of lipid species as those
adsorbed on SWCNT (Figure 1 D) were prepared by sonication in HBS (Hepes buffered
saline, pH 7.4). SUVs were mixed with FITC-SWCNTs (SWCNTs/lipid ratio 120 μg : 360
nmol) in the presence or absence of SP-D followed by sonication (3×15 sec, ice bath).
Unbound lipids and protein were removed by washing thrice with HBS (30,000 × g, 30
min).
Phagocytosis of SWCNTs by RAW264.7 mouse macrophage cells
RAW264.7 murine macrophages were cultured overnight, then washed with PBS and
incubated with uncoated or surfactant lipid/protein-coated SWCNTs for 1 h at 37° C.
Unbound/uninternalized SWCNTs were removed by washing with PBS, and internalized
particles were determined by flow cytometry (FACScan, Becton-Dickinson, Rutherford, NJ)
in the presence of trypan blue to exclude fluorescence from macrophage-bound SWCNTs.
Statistics
The results are presented as mean ± S.D. values from three experiments, and statistical
analyses were performed using Student's t-test. The statistical significance of differences
was set at p< 0.05.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. MS analysis of lipids adsorbed on SWCNTs 24 hrs after pharyngeal aspiration in mice
A. Base peak chromatogram and LC/MS spectra of individual lipid classes (insets) of
material extracted from SWCNTs from mice after pharyngeal aspiration. PC dominates with
respect to amount although this is not reflected in the TIC trace since PC ionizes to a much
lesser extent in negative ion mode. B. Control spectrum (upper panel) and chromatogram
(lower panel) from BAL fluid run over sucrose gradient. C. Control spectrum (upper panel)
and chromatogram (lower panel) from non-treated CNT's. Note that typical lipid mass ions
were not seen in the absence of SWCNTs, indicating the absence of cell contamination from
extracts of SWCNTs suspensions alone. D. Positive mode MALDI spectrum of lipids
extracted from SWCNTs from mice after pharyngeal aspiration confirming PC (16:0/16:0,
m/z 734, sodium adduct, m/z 756) as one of the major lipid species. E. Distribution of
phospholipid classes in material associated with SWCNTs. Only one species of
sphingomyelin was present which was in very low abundance. Fatty acyl chain distributions
as well as percent abundances are given in Table 1 and indicates that dipalmitoyl
phosphatidylcholine (DPPC, m/z 768, chloride adduct) dominates (up to 60%) as the major
PC species while 16:0/18:1, 16:0/18:2 PG (combined) and 16:0/16:0 PG dominate as the
major PG species (up to 52 and 26%, respectively). The most abundant species of PC and
PG are highlighted in red.
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Figure 2. Identification of proteins bound to SWCNTs 24 hrs after pharyngeal aspiration in mice
SDS-PAGE of BALf proteins associated with SWCNTs. The gels were stained by Silver
SNAP stain kit. MS analysis of SWCNTs-bound proteins recovered from in-gel digestion
revealed the presence of several surfactant proteins (SP). The sequences determined from
matches of mass ions by mass profile fingerprinting are shown.
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Figure 3. Structural characterization of interactions of surfactant lipids and proteins with
SWCNTs by AFM
A. AFM height image and B. Section analysis of carboxylated SWCNT with a height profile
of 1.9 nm (red arrow), 2.0 nm (green arrow), and 2.6 nm (black arrow). C. AFM height
image and D. Section analysis of lipid-coated carboxylated SWCNTs. The lipid-coated
carboxylated SWCNT demonstrated a height profile of 6.0 nm (red arrow), 11.4 nm (green
arrow), and 10.7 nm (black arrow). E. AFM height image and F. Section analysis of SP-D-
coated carboxylated SWCNTs; the height profile for the SP-D-coated carboxylated SWCNT
was determined to be 7.0 nm (red arrow), 6.2 nm (green arrow), and 5.6 nm (black arrow).
G. AFM height image of phospholipid/SP-D-coated carboxylated SWCNTs. H. Section
analysis indicated that the phospholipid/SP-D-coated SWCNT height profile was 16.9 nm
(red arrow), 16.5 nm (green arrow), and 8.8 nm (black arrow).
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Figure 4. Computer modeling of SWCNTs binding with phospholipids and SP-D
The predicted binding pose of A. Lowest energy conformation of DPPC, B. DPPC bound
along the axis of SWCNT, lowest energy conformation of C. PG, D. PS, and E. PE. F. The
lipid coating model generated using the PG bound form of SWCNT shown in (C). The
SWCNT is represented as spheres and colored in grey. The different phospholipids DPPC,
PG, PS and PE are rendered as spheres and colored in cyan, green, white and magenta,
respectively. In all cases the N, O and P atoms are colored in blue, red and orange –
respectively. The predicted binding sites of DPPC (G) and SWCNTs (H) on SP-D. The 3D
structure of SP-D is colored according to the different chains and is represented as a cartoon.
The structures of both DPPC and SWCNT are represented as sticks. The SWCNT is colored
in grey and the structure of DPPC is colored based on its atoms, i.e., carbon, oxygen and
nitrogen atoms in yellow, red and blue, respectively.
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Figure 5. Effects of surfactant phospholipids and SP-D on the uptake of SWCNTs by RAW 264.7
macrophages
RAW264.7 macrophages were cultured overnight, then washed with PBS and incubated
with SWCNTs or phospholipid-coated SWCNTs or phospholipid/SP-D-coated SWCNTs for
1 h at 37°C. The cells were then washed, detached and resuspended in 0.2% trypan-blue for
flow cytometric analysis. Phagocytosis is reported as the fraction of FITC-positive
macrophages. Insert-histogram presentation of flow cytometry data for macrophages
incubated with SWCNT, alone (open trace), phospholipid-coated SWCNTs (red),
phospholipid-coated SWCNTs deficient for PG and PS. The data are presented as percent
phagocytosis mean values ± S.D. of three independent experiments. ** = p < 0.01, *** = p <
0.001.
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Table 1
Fatty acyl chain analysis of the dominant PC and PG species.
m/z Fatty acyl chains % abundance
Phosphatidylglycerol
745, 747 16:0/18:2/, 16:0/18:1 52.0
721 16:0/16:0 25.6
793 18:2/20:4 13.1
769 18:2/18:2 9.3
Phosphatidylcholine1
768 16:0/16:0 58.8
792 16:1/18:1, 16:0/18:2 19.1
740 16:0/14:0 11.2
778 16:0p/18:2, 16:1p/18:1 5.7
808 18:0p/18:1, 18:0/20:4 (no adducts) 5.2
Phosphatidylethanolamine
746 18:0/18:0 44
762 18:2/20:4, 16:0/22:6 36
722 16:0p/20:4 20
Phosphatidylinositol
885 18:0/20:4 77
857 16:0/20:4 23
Phosphatidylserine
834 18:0/22:6 80
810 18:0/20:4, 20
Sphingomyelin1,2
767 d18:0/18:0 100
p-plasmenyl.
1
Masses ran as Cl adducts, except where indicated,
2
sphingoid base/acyl chains,
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